14 | 15 | 16 NOVEMBER

ABU DHABI

Organizing Committee

Mr. Khalifa Nasser Al Shamsi

Chief Financial Officer

SEHA

United Arab Emirates

Mr. Khalifa Nasser Al Shamsi

Chief Financial Officer

Chief Financial Officer, Al Ain Region, SEHA

Dr. Khalid Saeed Balaraj

Chair of Oncology Service

Tawam Hospital

United Arab Emirates

Dr. Khalid Saeed Balaraj

Chair of Oncology Service

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Dr. Hamda Salem Al Neyadi

Group Marketing and Communications Director

Abu Dhabi Health Services Company - SEHA

United Arab Emirates

Dr. Hamda Salem Al Neyadi

Group Marketing and Communications Director

.

Mr. Mohammad Mah'D Saleh

Oncology Center Manager

Tawam Hospital

United Arab Emirates

Mr. Mohammad Mah'D Saleh

Oncology Center Manager

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.